Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice (Q34181861)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice |
scientific article |
Statements
1 reference
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice (English)
1 reference
Domenico Coppola
1 reference
Maria E Balasis
1 reference
Kara D Forinash
1 reference
Y Ann Chen
1 reference
William J Fulp
1 reference
Andrew D Hamilton
1 reference
Jin Q Cheng
1 reference
Saïd M Sebti
1 reference
1 May 2011
1 reference
1 reference
17
1 reference
2852-2862
1 reference
Identifiers
1 reference
1 reference
1 reference